South Africa: Medical Scheme Reserves - a Shot in the Arm for Mass Covid-19 Vaccination Campaign

analysis

Were it not for a much-maligned solvency policy used to regulate medical schemes 20 years ago, schemes would most likely be struggling to cover their own members for Covid-19 vaccines and be unable to fund millions of uninsured members of the public.

But this solvency policy, opposed by many schemes, has allowed a situation to develop in which the industry is now being looked to, to assist in saving the people of the country from the ravages of Covid-19 by helping to finance the acquisition and distribution of vaccines.

South Africa's medical scheme industry has been in good health in recent years: in 2018/19 the Council for Medical Schemes reported that R66-billion was held in reserves. This figure is likely to have grown significantly, taking into account the Covid-19 pandemic during which much less than normal was paid out by schemes - caused by the sudden drop in demand of non-Covid related healthcare procedures.

It was not always this way.

In 2000 and for a few years after, the industry fought a pitched and often ugly battle with regulators to avoid a major policy thrust to make schemes sustainable, restore them to solvency - and keep them solvent so they...

More From: Daily Maverick

Don't Miss

AllAfrica publishes around 600 reports a day from more than 130 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.